Search This Blog

Saturday, November 9, 2024

 Now, as Donald Trump prepares to return to the White House, Mexican cartels, Chinese chemical companies, money laundering networks across North America, and US-based drug dealers are on notice that the boom times under the Biden-Harris regime's open southern border policies will soon be coming to an end. 

If Trump follows through with his 2023 campaign promise to "wage war" against Mexican drug cartels, then Americans could expect an end to the horrific 100,000 US drug death overdose crisis per year caused by fentanyl and other drugs - much of which starts as precursor chemicals shipped from China, cooked into fentanyl by Mexican cartels, then flooded in the Lower 48. 

Here's Trump's action plan to destroy the cartels:

  • Restore all Trump border policies and fully secure border

  • Deploy all necessary military assets, including the U.S. Navy, to impose a full naval embargo on the cartels, to ensure they cannot use our region's waters to traffic illicit drugs to the U.S.

  • Order the Department of Defense to make appropriate use of special forces, cyber warfare, and other covert and overt actions to inflict maximum damage on cartel leadership, infrastructure, and operations

  • Designate the major drug cartels as foreign terrorist organizations

  • Cut off the cartels' access to the global financial system

  • Get full cooperation of neighboring governments to dismantle the cartels, or else fully expose the bribes and corruption that protect these criminal networks

  • Ask Congress to ensure drug smugglers and traffickers can receive the Death Penalty

Trump's team released this video in December 2023 titled "President Donald J. Trump Declares War on Cartels." 

Now the question arises: Does the Trump-Vance team still hold these strong cartel-busting views after announcing them nearly a year ago?

Absolutely... 

Here's JD Vance on the campaign trail in late October: "On behalf of every American who has lost a loved one due to this border crisis, we're going to kick some cartel ass when President Donald J. Trump takes office."

Not too long ago, Trump announced financial armageddon for Mexican cartels: "I'm announcing that for the first time under my administration, we are seizing the assets of the criminal gangs and drug cartels and we will use those assets to create a compensation fund to provide restitution for the victims of migrant crime." 

At the Republican National Convention, Tom Homan, who served as the acting director of Immigration and Customs Enforcement between 2017 and 2018, told Mexican cartels: "You're done." 

Americans are desperately hoping for closed borders and a resolution to this drug death chaos and illegal alien invasion. Trump's historic election sweep shows just that. Now get to work, Mr. President.

In our view, the Trump team next year could start by disrupting the financial networks - or command and control centers - of cartels. Trump already mentioned seizing assets, but what's rarely mentioned is the possibility of sanctioning Mexican banks.

https://www.zerohedge.com/geopolitical/show-no-mercy-trumps-campaign-pledge-annihilate-mexican-cartels-goes-viral

US lawmakers press top chip equipment makers for details on China sales

China hardliners in Congress are calling on the world's foremost semiconductor equipment makers - KLA, LAM, Applied Materials, Tokyo Electron and ASML - to provide details of their sales to China.

Republican John Moolenaar and Democrat Raja Krishnamoorthi sent letters to the companies on Thursday, according to a Friday press release, amid pushback against expected U.S. rules that crack down further on tool shipments to China.

"We understand that some (toolmakers) believe we should limit the expansion of...future unilateral U.S. controls, due to perceived impacts on the competitiveness of this sector," the lawmakers wrote. "However, enhanced export controls simply are not mutually exclusive with a robust and thriving (toolmaking) industry," they added.

U.S. firms KLA, LAM, Applied Materials, as well as Japan-based Tokyo Electron and Dutch ASML did not immediately respond to requests for comment.

But the letters come amid opposition even from Democrats to the Biden administration's long-delayed next round of export regulations, aimed at further stymying Beijing's access to toolmaking equipment.

Washington fears that progress in Chinese chipmaking capabilities, fueled by U.S., Dutch and Japanese equipment sales, is fueling the modernization of China's military.

But it has struggled to bring allies Japan and the Netherlands on board with another round of upcoming measures, leading U.S. industry to fear that U.S. companies will be unfairly harmed by them.

In an August letter, California Democrats argued that a further round of export controls "could send longstanding U.S. companies into a death spiral," because U.S. allies have not imposed similarly aggressive China export curbs on their own companies.

https://www.marketscreener.com/quote/stock/APPLIED-MATERIALS-INC-4850/news/US-lawmakers-press-top-chip-equipment-makers-for-details-on-China-sales-48310561/


Judge rules New York cannot block Texas from sending migrant buses

 A state court judge ruled that New York City cannot block Texas from sending buses with migrants, who have crossed the U.S.-Mexico border, to the Big Apple. 

Judge Mary Rosado said in a ruling on Thursday the law New York City Mayor Eric Adams (D) sought to use to curb the flow of migrant buses into the city is unconstitutional, The Associated Press (AP) reported

Rosado said it “violates a fundamental right — the right to travel,” and that states cannot police interstate travel of passengers solely on their socioeconomic background, according to AP. She said the city should set its sights on Congress for a solution, not impose an “antiquated, unconstitutional statute to infringe on an individual’s right to enter New York based on economic status.”

The court slapped down the lawsuit Adams filed against a dozen bus and transportation companies in January this year. In hopes of cracking down on the influx of migrant buses into New York City, Adams sued 17 charter companies and sought $708 million to cover the price of taking care of migrants sent over by Texas Gov. Greg Abbott (R). 

Abbott started sending buses filled with migrants who crossed the southern border to cities run by Democrats in April 2022 to protest the way President Biden’s administration has handled the influx of people through the border. 

“New York City has and will always do our part to manage this humanitarian crisis, but we cannot bear the costs of reckless political ploys from the state of Texas alone,” Adams said at the time while Abbott denounced the lawsuit as “baseless.” 

Prior to filing a lawsuit, Adams issued an emergency executive order in December last year to crack down on bus arrivals, requiring bus operators to provide notice at least 32 hours before their expected arrival to the city. 

https://thehill.com/regulation/court-battles/4982196-judge-rules-new-york-cannot-block-texas-migrant-buses/

Italy's Recordati sees no impact from potential US pharma tariffs

  Italian drug maker Recordati is not concerned about potential new U.S. tariffs under president-elect Donald Trump as it expects them to have no impact on its rare diseases business, the company's chief financial officer said on Friday.

One of the main concerns in Europe and elsewhere from Trump's re-election victory this week is his campaign pledge to impose tariffs on a wide range of goods, including pharmaceutical products.


"Our business in the U.S. is only on rare diseases. I don't know what the intentions are, the rare disease business generally has different dynamics (from other potentially affected pharma products)," Luigi La Corte told Reuters.

The CFO noted that the U.S. has become Recordati's leading market in terms of turnover, with just under 17% of the total.

La Corte also said Recordati would unveil its 2025 outlook in February, along with preliminary 2024 results, taking into account its recent acquisition from Sanofi of the global rights to Enjaymo, a rare immune disorder drug.

On the M&A front, he said Recordati continued to look for opportunities in the speciality, primary care and rare diseases sectors both in Europe and the U.S., and was examining several dossiers.

Earlier on Friday, Recordati confirmed its 2024 guidance, which it raised in July, after posting a 11.8% jump in its nine-month core profit boosted by a strong business momentum in the speciality and primary care and rare diseases segments.


https://uk.finance.yahoo.com/news/italys-recordati-sees-no-impact-164039645.html

Friday, November 8, 2024

Breast cancer vaccine produces immune response: Cleveland Clinic

 A vaccine against triple-negative breast cancer was found to produce an immune response and was well tolerated by most patients during an ongoing clinical trial. 

The findings will be presented by health system researchers Nov. 6-10 at the Society for Immunotherapy of Cancer Annual Meeting, according to a Nov. 8 news release from Cleveland Clinic.

The first phase of the vaccine trial was launched in 2021 by the Defense Department and conducted at Cleveland Clinic in partnership with Anixa Biosciences. The second phase will launch in 2025 to determine the vaccine's efficacy over two to three years. 

The vaccine targets a protein present in most triple-negative breast cancers. The vaccine is designed to prompt the immune system if cancer develops, attack the tumor and keep it from growing, the release said.

https://www.beckershospitalreview.com/oncology/breast-cancer-vaccine-produces-immune-response-cleveland-clinic.html

Texas sues another physician over gender-affirming care to minors

 A third physician in Texas is facing legal action over a state law that restricts medical providers from providing gender transition-related care to minors. 

Attorney General Ken Paxton's office on Nov. 8 announced a lawsuit against Brett Cooper, MD, claiming the physician illegally prescribed hormone therapy drugs to 15 minors most recently as Sept. 25. SB 14, the bill banning surgeries, puberty blockers and hormone therapy for minors, went into effect in September 2023. 

The complaint, filed Nov. 4 in the District Court of Collin County, also accuses Dr. Cooper of falsifying medical and billing records to conceal the prescriptions. The physician works at Dallas-based UT Southwestern Medical Center and has hospital privileges at Children's Medical Center Dallas. The hospitals did not immediately respond to The Dallas Morning Newsrequest for comment on the matter Nov. 8. 

Dr. Cooper has been an outspoken advocate against Texas' ban on gender-affirming healthcare. The attorney general's complaint references former posts Dr. Cooper shared on social media platform X in which he criticized the legislation. 

This marks the third time Mr. Paxton's office has taken legal action against physicians regarding SB 14 violations since October. On Oct. 17, his office announced a similar lawsuit against May Chi Lau, a Dallas-based UT Southwestern Medical Center physician. Toward the end of the month, the attorney general also sued Hector Granados, MD, an El Paso-based physician, for prescribing puberty blockers and hormone therapy drugs to minors. 

"Texas has prohibited doctors from prescribing these damaging and unfounded 'gender transition' drugs to children," Mr. Paxton said in a news release. "These medical professionals cannot willfully ignore the law and endanger the health of young people."

The American Medical Association and American Academy of Pediatrics refute claims that gender-affirming care is "experimental," and support related treatments for minors with gender dysphoria. 

https://www.beckershospitalreview.com/legal-regulatory-issues/texas-sues-another-physician-over-gender-affirming-care-to-minors.html

BioNTech upped to Buy from Neutral by Goldman

 Target to $137 from $90

https://finviz.com/quote.ashx?t=BNTX&p=d